Aspire Biopharma Holdings (ASBP) Other Operating Expenses (2024 - 2026)
Aspire Biopharma Holdings' (ASBP) quarterly Other Operating Expenses came in at $296723.0 in Q1 2026, up 34.97% year-on-year from $219839.0 in Q1 2025, and up 196.62% on a QoQ basis from $100035.0 in Q4 2025.
Aspire Biopharma Holdings (ASBP) Other Operating Expenses (2024 - 2026) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has 3 years of Other Operating Expenses data on file, last reported at $296723.0 in Q1 2026.
- On a quarterly basis, Other Operating Expenses rose 34.97% year-over-year to $296723.0 in Q1 2026; TTM through Mar 2026 was $779442.0, a 310.0% increase from a year earlier, with the FY2025 full-year figure at $923914.0, up 540.02% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $296723.0, up from $100035.0 in the prior quarter.
- Over the last five years, Other Operating Expenses for ASBP reached as high as $425489.0 in Q3 2025 and fell as low as -$86423.0 in Q2 2024.
- Historically, Other Operating Expenses has averaged $108894.2 across 3 years, with a median of $40012.0 in 2024.
- Across the five-year window, Other Operating Expenses jumped 2451.2% in 2025 and surged 34.97% in 2026, its largest moves.
- Year by year, Other Operating Expenses stood at $40012.0 in 2024, then surged by 150.01% to $100035.0 in 2025, then soared by 196.62% to $296723.0 in 2026.
- Per Business Quant data, the three most recent Other Operating Expenses figures were $296723.0 in Q1 2026, $100035.0 in Q4 2025, and $425489.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Aspire Biopharma Holdings | 1.21 Mn | -619,284.29 | 5,750.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 296,723.00 |
| Dec 31, 2025 | 100,035.00 |
| Sep 30, 2025 | 425,489.00 |
| Jun 30, 2025 | -42,805.00 |
| Mar 31, 2025 | 219,839.00 |
| Dec 31, 2024 | 40,012.00 |
| Sep 30, 2024 | 16,678.00 |
| Jun 30, 2024 | -86,423.00 |
| Mar 31, 2024 | 10,500.00 |